Home › Funds › Ally Bridge Group (NY) LLC › CLYM

Ally Bridge Group (NY) LLC position in CLYM

CLIMB BIO INC · Health Care

Ally Bridge Group (NY) LLC reported holding 249,172 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 2.87% of its reported portfolio and ranking #10 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed CLYM holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)249.17K sh
Reported value held$3.25M
Portfolio Weight2.87%
First reportedQ2 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's CLYM position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in CLYM in Q2 2024 at 500,000 shares (US$3.6M). The position peaked in Q3 2024 at 1,229,292 shares, worth US$6.3M. Across 4 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 249,172 shares valued at US$3.2M. Notable position changes include a 146% increase in Q3 2024 (shares fell 65% over the following quarter), a 38% trim in Q4 2024 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 500.00K $3.56M New
Q3 2024 1.23M $6.26M Add
Q4 2024 760.23K $1.37M Reduce
Q2 2026 249.17K $3.25M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held CLYM?

Ally Bridge Group (NY) LLC has disclosed CLYM holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

What is Ally Bridge Group (NY) LLC's current position in CLYM?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 249.17K shares of CLYM (CLIMB BIO INC), valued at $3.25M, representing 2.87% of its reported portfolio and ranking #10.

Has Ally Bridge Group (NY) LLC been buying or selling CLYM?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC newly opened its position in CLYM. The position peaked in Q3 2024 at 1.23M shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.